Resilience and distress among adolescents and young adults receiving hematopoietic cell transplantation: The Promoting Resilience in Stress Management randomized trial

Author:

Rosenberg Abby R.12345ORCID,Taylor Mallory R.56ORCID,Fladeboe Kaitlyn M.56,Zhou Chuan57,Levine Deena R.8ORCID,Johnston Emily E.9,Freyer David R.1011,Comiskey Liam14,Junkins Courtney C.14,Bradford Miranda4,Odom J. Nicholas12ORCID,Baker K. Scott513,Yi‐Frazier Joyce P.14

Affiliation:

1. Department of Psychosocial Oncology and Palliative Care Dana‐Farber Cancer Institute Boston Massachusetts USA

2. Department of Pediatrics Boston Children’s Hospital Boston Massachusetts USA

3. Department of Pediatrics Harvard Medical School Boston Massachusetts USA

4. Center for Clinical and Translational Research Seattle Children’s Research Institute Seattle Washington USA

5. Department of Pediatrics University of Washington School of Medicine Seattle Washington USA

6. Ben Towne Center for Childhood Cancer Research Seattle Children’s Research Institute Seattle Washington USA

7. Center for Child Health, Behavior, and Development Seattle Children’s Research Institute Seattle Washington USA

8. Division of Quality of Life and Palliative Care Department of Oncology St. Jude Children’s Research Hospital Memphis Tennessee USA

9. Institute for Cancer Outcomes and Survivorship School of Medicine University of Alabama at Birmingham Birmingham Alabama USA

10. Departments of Pediatrics, Medicine, and Population and Public Health Sciences Keck School of Medicine University of Southern California Los Angeles California USA

11. Cancer and Blood Disease Institute Children’s Hospital Los Angeles Los Angeles California USA

12. School of Nursing University of Alabama at Birmingham Birmingham Alabama USA

13. Clinical Research Division Fred Hutchinson Cancer Center Seattle Washington USA

Abstract

AbstractBackgroundAdolescents and young adults (AYAs) receiving hematopoietic cell transplantation (HCT) are at high risk of poor psychosocial health. This study aimed to determine whether the Promoting Resilience in Stress Management (PRISM) intervention mitigated these risks during the first 6 months posttransplant.MethodsThis multisite, parallel, randomized trial was conducted from April 2019 to March 2023. Eligible AYAs were aged 12–24 years, English speaking, and within 1 month of HCT for cancer or cancer predisposition syndrome. They were assigned 1:1 to PRISM (a brief, skills‐based intervention targeting “resilience resources” [stress management, goal setting, cognitive reframing, and meaning making]) or usual care (UC). Outcomes included total symptoms of depression and anxiety (Hospital Anxiety and Depression Scale; primary outcome), hope (Snyder Hope Scale), resilience (10‐item Connor–Davidson Resilience Scale), and health‐related quality of life (HRQOL; Pediatric Quality of Life Inventory Cancer Module). Analyses leveraged multivariable linear regressions; exploratory analyses assessed the influence of baseline depression or anxiety.ResultsOf 94 enrolled and randomized AYAs, the mean age was 16.7 years (SD, 4.2); 43 (46%) were female, 56 (60%) were non‐Hispanic White, 22 (23%) were Hispanic, and nine (10%) were Black. Most (77%) had leukemia. Of n = 50 randomized to PRISM and n = 44 to UC, 37 (74%) and 33 (73%) completed all study procedures, respectively. In intention‐to‐treat analyses, PRISM did not affect 6‐month depression and anxiety (β = −1.1; 95% CI, −3.7 to 1.5), hope (β = 0.83; 95% CI, −3.3 to 4.9), resilience (β = −0.01; 95% CI, −3.0 to 3.0), or HRQOL (β = 1.5; 95% CI, −4.7 to 7.9). Among AYAs with preexisting anxiety or depression, PRISM recipients reported greater 6‐month improvements in hope (score change, +3.71; SD, 6.9) versus UC recipients (score change, −2.76; SD, 6.5) (p = .04).ConclusionsResilience coaching did not influence outcomes in this sample. Exploratory findings suggest it may be more effective when directed toward those with concurrent distress.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3